News

May 13, 2019

Share this:

Meet with Hexoskin at the American Thoracic Society (ATS) International Conference 2019 in Dallas on May 17-22!

Hexoskin will be attending the ATS International Conference 2019 in Dallas, TX, on May 17-22, 2019.

ATS is home for pulmonary, critical care, and sleep professionals, where they discuss and promote their experiences, challenges, and research. Attendees can learn about the latest advances in understanding pulmonary diseases, critical illness, and sleep disorders as well as improving patient's experience. It is truly where today’s science meets tomorrow’s care.

The Hexoskin Team will be hosting meetings at the Kay Bailey Hutchison Convention Center in Dallas, Exhibit Hall - Booth #1408. Our team will be presenting demos of its new clinically validated collection of Smart Garments for clinical research along with the Hexoskin Connected Health Platform.

A CONNECTED HEALTH PLATFORM BUILT AROUND YOU AND THE PATIENT!

With the rising incidence of chronic respiratory diseases, such as asthma, cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), and obstructive sleep apnea (OSA), health clinicians and research investigators are increasingly looking for solutions to continuously monitor patients living with chronic and rare respiratory diseases.

Current solutions for monitoring the patients' conditions are not acceptable. Patients must often undergo a battery of tests at the hospital or research site, allowing physicians and researchers to rely only on snapshots in time to evaluate patients’ overall respiratory health status. The equipment available for monitoring patients remotely is bulky and must be set up by specialized personnel.

Validated in over 65 independent scientific publications since 2013, the Hexoskin Smart Garments allow the continuous and non-invasive remote monitoring of the patients’ cardiac and respiratory function, activity, and sleep. The Hexoskin Smart Garments are washable and designed to be comfortably worn underneath clothes.

Hexoskin can reduce the number of medical visits and/or prevent costly complications and hospital stays. Our end-to-end Connected Health Platform provides the communication and reporting tools to connect patients with clinicians and researchers. With Hexoskin, patients can pursue their normal activities or enroll in a rehabilitation program while being connected and closely monitored by clinicians and researchers.

If you're a Pharma, a Medical company or a Healthcare provider interested in patient remote monitoring with digital markers, sensors, and AI, visit us at Booth #1408 in the Exhibit Hall to see a live demo or book us a meeting to discuss how Hexoskin could support you. Don't hesitate to contact us through our website www.hexoskin.com or the ATS2019 website, section "partnering".

See you in Dallas!

April 24, 2019

Accelerator › Arizona State University › Connected Health › Conventions & Events › MayoClinic › Medtech › Validations ›

Share this:

Hexoskin Selected for the Inaugural Mayo Clinic and ASU MedTech Accelerator

Our team is excited to announce that Hexoskin is one of only six medical technology companies selected by the Mayo Clinic and Arizona State University (ASU) for its inaugural MedTech Accelerator cohort. The accelerator, which is part of the Mayo Clinic Arizona State University Alliance for Health Care, was designed specifically for medical device and health care technology companies looking to partner with Mayo Clinic and ASU.

"The inaugural cohort of the program consists of six extremely dynamic startups with product offerings we feel are poised to improve patient care and outcomes through their new innovations," says Steven Lester, M.D., a Mayo Clinic cardiologist and medical director of the accelerator. Dr. Lester, professor of Medicine, is also associate medical director of Mayo Clinic's Department of Business Development.

"At Hexoskin we see a great fit between our vision for at-home patient monitoring, post-acute care, and chronic disease management and Mayo Clinic's mission to put the best interest of the patient first." says Pierre-Alexandre Fournier, MScA, Co-founder and CEO of Hexoskin.

Hexoskin provides a seamless integration of its smart shirts for vital signs monitoring with hospitals’ existing processes to improve upon the patient experience. The accelerator program gives Hexoskin the opportunity to collaborate with the country’s most distinguished medical mentors and researchers and develop new clinical opportunities for Hexoskin technology.

About Hexoskin
Founded in 2006 in Montreal, Carré Technologies Inc. (Hexoskin) is involved in the development of non-invasive sensors, software & applications, data science & AI services. Hexoskin’s mission is to record and organize personal health information and make it accessible and useful.

Source: https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-asu-select-six-startups-for-inaugural-medtech-accelerator-cohort/

April 02, 2019

Connected Health › research › Sleep › sports performance ›

Share this:

FC Barcelona - Barça Innovation Hub (BIHub) and Allianz align themselves to promote a study on sleep and young athletes

Hexoskin is very proud to be part of this study on sleep and young athletes with FC Barcelona, a world leader in the development of young athletes, and Allianz, one of the world's largest insurers.

Hexoskin has been involved in sleep research since 2012. We share the views of FC Barcelona that we need to do more research on sleep and young athletes to optimize their health and their gameplay. There's more than one way to monitor sleep with Hexoskin smart shirts, and this study allows us to advance of our knowledge of sleep in teenage athletes.

"The information gathered will be processed by doctors at the Adsalutem Institute, and FC Barcelona will provide data on the performance of the analysed athletes to be cross-referenced with those obtained on the quality of their sleep. A study will be shared detailing the conclusions obtained. The Adsalutem Institute has the academic support of the Universitat Internacional de Catalunya (UIC) within the framework of the 'Center for Studies of Sleep Medicine', in which both entities collaborate in the scientific and teaching fields."

About Hexoskin
Founded in 2006 in Montreal, Carré Technologies Inc. (Hexoskin) is involved in the development of non-invasive sensors, software & applications, data science & AI services. Hexoskin’s mission is to record and organize personal health information and make it accessible and useful.

Source: https://www.fcbarcelona.com/en/club/news/1111799/the-bihub-and-allianz-align-themselves-to-promote-a-study-on-sleep#

March 05, 2019

API › developers › development › Health Sensors › Products&Software › software › Update › wearable technology ›

Share this:

Hexoskin Application Programming Interface (API) Update

We've done important improvements to the platform over the past year. We've improved the speed of many frequently used functions, and added security and privacy measures that will benefit both developers and users. Some of the improvements mean we'll bring down older versions of the Hexoskin API, including versions supporting OAuth 1.0. That means all authentication will need to be made using OAuth 2.0 starting in April.

The current Hexoskin API version is 4.5.0.*

*API versions older than 4.0.0 will be retired on Wednesday April 10th, 2019 12PM EDT.

We invite you to go to our Developer page to learn more about developer tools and documentation. For more information, please contact the Hexoskin API team: api@hexoskin.com

About Hexoskin
Founded in 2006 in Montreal, Carré Technologies Inc. (Hexoskin) is involved in the development of non-invasive sensors, software & applications, data science & AI services. Hexoskin’s mission is to record and organize personal health information and make it accessible and useful.

February 28, 2019

astronaut health › Astroskin › canadian space agency › Conventions & Events › health technology › space › space health › Space Research ›

Share this:

Government of Canada confirmed Canada's commitment to Nasa Lunar Gateway program

The government of Canada confirmed today, Thursday, February 28, 2019, Canada's commitment to the Lunar Gateway space mission led by the United States, to give Canada's space program a new momentum. The Prime Minister of Canada Justin Trudeau announced historic investments in Canada’s space program. The Government of Canada will invest $2.05 billion over 24 years for Canada's space program. It will help grow innovative Canadian companies of all sizes by supporting the development of new digital and artificial intelligence-based technologies, and by opening new markets for Canadian businesses (Prime Minister's Office).

This investment will also give Canadian astronauts the opportunity to participate in missions to space and our scientists a chance to conduct cutting-edge research that cannot be done on Earth.

At Hexoskin, since we started working with Canadian Space Agency in 2011, we designed medical monitoring systems with the goal of fulfilling the autonomy requirements of future missions to the Moon and Mars. The spillover effects of space exploration projects are applicable beyond human spaceflight and find applications on earth that benefit humanity.

The technologies we're developing will allow a greater number of people to access regular care, especially patients with chronic cardiovascular and respiratory diseases. The software being developed for medical autonomous systems has the potential to deliver automated health services, affordable and accessible 24/7.

After today's announcement, we hope that Hexoskin will be able to contribute to future missions to the Moon, by supplying innovative medical technologies for crew members taking the trip.

Pierre-Alexandre Fournier
CEO at Hexoskin

About Hexoskin
Founded in 2006 in Montreal, Carré Technologies Inc. (Hexoskin) is involved in the development of non-invasive sensors, software & applications, data science & AI services. Hexoskin’s mission is to record and organize personal health information and make it accessible and useful.

February 22, 2019

Artificial Intelligence › cardiovascular › Cardiovascular Health Research › clinical trials › digital health › health technology › hexoskin › research › respiratory › wearable technology › webinar ›

Share this:

Join Us for the upcoming Hexoskin Live Webinar on Artificial Intelligence, Cardiovascular & Respiratory Health Research with Hexoskin

It's not too late to register for this Hexoskin Live Webinar on Artificial Intelligence, Cardiovascular & Respiratory Health Research with Hexoskin, that will cover the latest fields of applications & research studies. Our guest speaker, Thomas Beltrame, PhD, will discuss his work with his fellow research team at University of Waterloo to evaluate cardiovascular & respiratory health with Hexoskin and machine learning.

We will also present how the Hexoskin and Astroskin end-to-end platforms can support research and professional organizations for their Machine Learning & Artificial Intelligence projects. Don't miss your chance to register!

HEXOSKIN LIVE WEBINAR:
Artificial Intelligence, Cardiovascular & Respiratory Health Research with Hexoskin
Wednesday, February 27, 2019, at 12:00 PM (EST) - via the Zoom Video Conferencing software

Speakers:
Pierre-Alexandre Fournier
CEO & Co-Founder, Hexoskin

Thu Ngan Trinh PhD
Clinical Applications Specialist, Hexoskin

Guest Speaker:
Thomas Beltrame PhD
Department of Physiotherapy - Federal University of São Carlos
Institute of Computing - University of Campinas

If you are unable to attend, you can still register and we will send you the recorded webcast by email afterward.

We look forward to your presence for this special event!

February 20, 2019

Artificial Intelligence › Cardiovascular Health Research › clinical trials › Conventions & Events › digital health › health technology › hexoskin › research › respiratory › wearable technology › webinar ›

Share this:

Live Webinar - Artificial Intelligence, Cardiovascular & Respiratory Health Research with Hexoskin

Join Us for our Hexoskin Live Webinar on February 27th!

We invite you to attend our Live Webinar on Artificial Intelligence, Cardiovascular & Respiratory Health Research with Hexoskin, that will cover the latest fields of applications & research studies. Our guest speaker, Thomas Beltrame, PhD, will discuss his work with his fellow research team at University of Waterloo to evaluate cardiovascular & respiratory health with Hexoskin and machine learning.

We will also present how the Hexoskin and Astroskin end-to-end platforms can support research and professional organizations for their Machine Learning & Artificial Intelligence projects.

HEXOSKIN LIVE WEBINAR:
Artificial Intelligence, Cardiovascular & Respiratory Health Research with Hexoskin
Wednesday, February 27, 2019, at 12:00 PM (EST) - via the Zoom Video Conferencing software

Speakers:
Pierre-Alexandre Fournier
CEO & Co-Founder, Hexoskin

Thu Ngan Trinh PhD
Clinical Applications Specialist, Hexoskin

Guest Speaker:
Thomas Beltrame PhD
Department of Physiotherapy - Federal University of São Carlos
Institute of Computing - University of Campinas

If you are unable to attend, you can still register and we will send you the recorded webcast by email afterward.

We look forward to your presence for this special event!

January 21, 2019

astronaut health › Astroskin › biometrics › canadian space agency › Connected Health › david saint jacques › space › Space Research › wearable tech › wearable technology ›

Share this:

Deployment of the Bio-Monitor in Space by Canadian Space Agency Astronaut David Saint-Jacques (CSA)

This week, Canadian Space Agency Astronaut David Saint-Jacques deployed and tested for the first time in space a new Canadian technology: the Bio-Monitor System.

This advanced smart shirt is designed to measure and record vital signs in microgravity environment. It will help keep an eye on astronauts' health and enable medical research in space by continuously measuring physiological data.

The Canadian Space Agency's Bio-Monitor is designed to easily send information to the ground, where scientists can monitor astronauts' physiology around the clock as they orbit the planet. Once operational it will be available for the next five years to all participating countries to the International Space Station.

To learn more: http://asc-csa.gc.ca/eng/missions/expedition58/default.asp.
Photo: CSA/NASA

December 05, 2018

Astroskin › Conventions & Events ›

Share this:

Astroskin / Bio-Monitor Successfully Launched to Space aboard Space X Dragon Spacecraft

Launch successful! En route to the International Space Station! The Bio-Monitor Astroskin system is part of the payload that was launched today in a Dragon spacecraft on a Falcon 9 rocket from Cape Canaveral, Florida.

About Hexoskin
Since 2006, Hexoskin’s mission is to develop sensors and health data infrastructure to generate clinical grade real-world evidence. The Astroskin demonstrates once again Hexoskin’s leadership in providing the industry leading sensors, software, and AI to push further our understanding of human physiology on earth and in space.

Contact our team to order Astroskin

November 30, 2018

astronaut health › Astroskin › Bio-Monitor › canadian space agency › digital health › space › Space Grade Smart Garments › space health › Space Research ›

Share this:

Join Us for the Bio-Monitor (Astroskin) launch to Space on December 4th!

We are happy to invite you to our live webcast on December 4th, that will broadcast the Astroskin launch to Space aboard Space X Dragon Cargo vehicle. Before the launch, Hexoskin's co-founders will discuss the history of the development of the Bio-Monitor system as well as a few case applications in Space and on Earth.

The Astroskin system is based on the Bio-Monitor designed for the Canadian Space Agency (CSA) to monitor the astronauts’ health in space on the International Space Station (ISS). It will be operational in space and available for all ISS participating countries to conduct space research for the next five years.

LIVE WEBCAST:
Astroskin Launch to the ISS aboard SpaceX Dragon Cargo
December 4, 2018, at 1:25 PM (EST)** - via the Zoom Video Conferencing software
** In case of postponement of the launch, you will receive a notification
with a new broadcast schedule.

Speakers:
- Pierre-Alexandre Fournier, CEO & Co-Founder, Hexoskin
- Jean-François Roy, CTO & Co-Founder, Hexoskin

Guest Speaker:
- Professor Richard L. Hughson Ph.D., University of Waterloo

If you are unable to attend, you can still register and we will send you the recorded webcast by email afterward.

We look forward to your presence for this special event!

About Hexoskin
Since 2006, Hexoskin’s mission is to develop sensors and health data infrastructure to generate clinical grade real-world evidence. The Astroskin demonstrates once again Hexoskin’s leadership in providing the industry leading sensors, software, and AI to push further our understanding of human physiology on earth and in space.

Contact our team to order Astroskin

« Previous 1 2 3 4 … 13 Next »